PULSION Medical Systems SE (PUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, PULSION Medical Systems SE (PUS) has a cash flow conversion efficiency ratio of 0.160x as of December 2017. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.30 Million ≈ $3.86 Million USD) by net assets (€20.60 Million ≈ $24.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PULSION Medical Systems SE - Cash Flow Conversion Efficiency Trend (2003–2017)
This chart illustrates how PULSION Medical Systems SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PUS total debt and obligations for a breakdown of total debt and financial obligations.
PULSION Medical Systems SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PULSION Medical Systems SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ensari Deri Gida Sanayi ve Ticaret AS
IS:ENSRI
|
0.094x |
|
Sierra Metals Inc.
TO:SMT
|
0.249x |
|
Falcon Oil & Gas Ltd
F:FAC
|
-0.012x |
|
Amrutanjan Health Care Limited
NSE:AMRUTANJAN
|
0.032x |
|
ADM Hamburg Aktiengesellschaft
F:OEL
|
0.392x |
|
Streamwide
PA:ALSTW
|
0.363x |
|
Contextlogic Inc
NASDAQ:LOGC
|
-0.023x |
|
DCW Limited
NSE:DCW
|
0.123x |
Annual Cash Flow Conversion Efficiency for PULSION Medical Systems SE (2003–2017)
The table below shows the annual cash flow conversion efficiency of PULSION Medical Systems SE from 2003 to 2017. For the full company profile with market capitalisation and key ratios, see PUS market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2017-12-31 | €20.60 Million ≈ $24.08 Million |
€3.30 Million ≈ $3.86 Million |
0.160x | -58.51% |
| 2016-12-31 | €20.60 Million ≈ $24.08 Million |
€7.95 Million ≈ $9.30 Million |
0.386x | +2.01% |
| 2015-12-31 | €20.60 Million ≈ $24.08 Million |
€7.80 Million ≈ $9.11 Million |
0.378x | +17.18% |
| 2013-12-31 | €17.59 Million ≈ $20.56 Million |
€5.68 Million ≈ $6.64 Million |
0.323x | -14.55% |
| 2012-12-31 | €23.84 Million ≈ $27.87 Million |
€9.01 Million ≈ $10.53 Million |
0.378x | +19.36% |
| 2011-12-31 | €21.10 Million ≈ $24.66 Million |
€6.68 Million ≈ $7.81 Million |
0.317x | -19.62% |
| 2010-12-31 | €16.56 Million ≈ $19.36 Million |
€6.52 Million ≈ $7.63 Million |
0.394x | +68.19% |
| 2009-12-31 | €16.98 Million ≈ $19.85 Million |
€3.98 Million ≈ $4.65 Million |
0.234x | +285.75% |
| 2008-12-31 | €16.24 Million ≈ $18.99 Million |
€986.00K ≈ $1.15 Million |
0.061x | -77.22% |
| 2007-12-31 | €17.05 Million ≈ $19.94 Million |
€4.55 Million ≈ $5.31 Million |
0.267x | +21.43% |
| 2006-12-31 | €14.63 Million ≈ $17.10 Million |
€3.21 Million ≈ $3.75 Million |
0.220x | -24.20% |
| 2005-12-31 | €11.25 Million ≈ $13.16 Million |
€3.26 Million ≈ $3.81 Million |
0.290x | +20.71% |
| 2004-12-31 | €9.20 Million ≈ $10.76 Million |
€2.21 Million ≈ $2.58 Million |
0.240x | +139.46% |
| 2003-12-31 | €8.31 Million ≈ $9.72 Million |
€833.00K ≈ $973.86K |
0.100x | -- |
About PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more